Product Information
DULOXETINE HCL DR 40 MG CAP is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $1.2439 per EA under NDC 51991075090. Its NADAC has been published 187 times since Mar 8, 2023.
FDA first approved this application on Jun 11, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991075090
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DULOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203088FDA Approved
6/11/2014
TE Code
AB
On Market Since
5/21/2018
Pharmacological Classes
Price Statistics
The NADAC for DULOXETINE HCL DR 40 MG CAP has been published 187 times since Mar 8, 2023, and over the history we have for it it has declined 29.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2439 per EA |
|---|---|
| All-time high | $1.7575 (Mar 15, 2023) |
| All-time low | $0.9547 (Jul 17, 2024) |
| 52-week high | $1.3767 |
| 52-week low | $1.0466 |
| Median price | $1.3052 |
| Average price | $1.3278 |
| Largest weekly change | +46.1% (Aug 21, 2024) |
| Weeks tracked | 187 |
| Tracking since | Mar 8, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Breckenridge Pharmaceutical Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DULOXETINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DULOXETINE HCL DR 40 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 40 MG CAP, manufactured by Breckenridge Pharmaceutical Inc., is $1.2439 per EA (NDC 51991075090), effective Sep 30, 2026.
How has the price of DULOXETINE HCL DR 40 MG CAP changed over time?
Over the history we have for it, the NADAC for DULOXETINE HCL DR 40 MG CAP has declined 29.2%. It has been tracked across 187 weekly CMS publications since Mar 8, 2023.
What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 40 MG CAP?
Since Mar 8, 2023, the NADAC for DULOXETINE HCL DR 40 MG CAP has ranged from a low of $0.9547 (Jul 17, 2024) to a high of $1.7575 (Mar 15, 2023), with a median of $1.3052 per EA.
Are there cheaper alternatives to DULOXETINE HCL DR 40 MG CAP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DULOXETINE HCL DR 40 MG CAP, is $1.0477 per EA — about 16% below DULOXETINE HCL DR 40 MG CAP.
Who manufactures DULOXETINE HCL DR 40 MG CAP?
DULOXETINE HCL DR 40 MG CAP (NDC 51991075090) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.